Cold Agglutinin is a rare disorder which leads to premature destruction of red blood cells. It primarily happens due to cold temperatures. However, there are various treatment options to limit the symptoms of this condition.
The treatment of cold agglutinin involves managing the symptoms by using a combination of medications and lifestyle modifications. The treatment methods for the patients depend on the severity of their symptoms. Here are a few such treatment methods:
| Treatment Procedure | Estimated Costs in India |
| Rituximab Injection (500 mg) | Rs. 17,000 |
| Blood Transfusion | Up to Rs. 10,000 (per unit) |
Most of the time, cold agglutinin happens by itself without any other underlying condition. It is known as the idiopathic or primary type of CAD. As for secondary CAD, they are triggered by other health conditions like:
CAD diagnosis is a multi-step process that consists of a comprehensive set of diagnostic laboratory tests and physical examination to determine the underlying cause of disease. Some other tests of the diagnosis process are for detecting lymphoid cancers, autoimmune diseases and infections.
Cold Agglutinin disease is rare, but primarily affects people between the ages of mid to late 60s. It is more prevalent in women than in men.
There is no definitive cure for CAD; available therapies focus on reducing hemolysis and controlling symptoms.
The treatments available today primarily focus on reducing haemolysis, managing anaemia, and other underlying conditions rather than eliminating underlying autoimmune conditions.
CAD complications occur due to severe anaemia, cold exposure, and ischemic complications in areas of the body that have been exposed to cold for long periods. Furthermore, there can also be risks of getting congestive heart failure due to haemolysis and severe anaemia.
The type of treatment that you require ultimately depends on the severity of your condition and symptoms. Your healthcare provider can treat CAD by treating the underlying symptoms.